Stockscreener 앱 받기
34.02
0.53%
-0.18
시간 외 거래:
33.90
-0.12
-0.35%
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta Faces Multiple Investor Investigations - stl.news
Rosen Law Firm Encourages Azenta, Inc. Investors to Inquire About Securities Class Action InvestigationAZTA - Business Wire
Azenta faces securities fraud probe after CEO r... - pluang.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Azenta, Inc.AZTA - PR Newswire
Azenta, Inc. (AZTA) Stock Forecasts - Yahoo Finance
Azenta, Inc. (AZTA) Options Chain - Yahoo! Finance Canada
Tax withholding reduces Azenta (NASDAQ: AZTA) CEO stake - Stock Titan
Azenta, Inc. (AZTA) Investor Outlook: Analyzing Growth Potential Amidst A 4.44% Upside - DirectorsTalk Interviews
Azenta Inc. (AZTA) Slips to $33.24 as Shares Test Key Support ZoneSymmetrical Triangle - siam.in
Azenta formalizes interim CEO pay and retention grants - The Globe and Mail
Azenta sets compensation terms for interim CEO and grants executive retention awards - Investing.com
Form 8K Azenta Inc For: 17 September By Investing.com - Investing.com UK
Azenta (NASDAQ: AZTA) Grants 15,272 Shares to Multiomics President Martin William E. III - Kalkine Media
Azenta (NASDAQ: AZTA) Grants Interim CEO Madaus Martin D 36,653 Shares at No Cost - Kalkine Media
Azenta (AZTA) interim CEO gets new year-long stock grant - Stock Titan
Azenta (AZTA) grants 4,586 stock units to accounting VP - Stock Titan
Azenta, Inc. (AZTA) awards 15,272 stock units to its top lawyer - Stock Titan
Azenta Inc. (AZTA) Steadies Near $30.17 as Traders Watch $31.68 ResistanceDouble Top - dars.gov.et
Azenta, Inc. (AZTA) accounting chief reports owning no stock - Stock Titan
Azenta (NASDAQ: AZTA) Secures Early $35M Vendor Loan Repayment, Finalizing $63M Cash Purchase - Kalkine Media
Azenta Completes B Medical Divestiture With Loan Repayment - theglobeandmail.com
Azenta Secures Full $35M Vendor Loan Repayment from B Medical Buyer Ahead of Schedule - Kalkine Media
Azenta completes B Medical sale as vendor loan repaid (AZTA) - Seeking Alpha
Azenta receives full $35M vendor loan repayment, completing $63M sale of B Medical Systems. - Pluang
Azenta Receives Full $35 Million Vendor Loan Repayment From B Medical Sale - citybiz
Azenta receives full $35.37M repayment, completes $63M sale of B Medical Systems - TradingView
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems - PR Newswire
AZTA Q2 2026 Earnings: EPS of $0.16 Beats Estimates by 37.8% While Shares Slip 1.96%ROE Trend Analysis - dars.gov.et
Azenta CEO resignation sparks 12% stock drop am... - Pluang
How Investors Are Reacting To Azenta (AZTA) CEO Resignation And Interim Leadership Change - simplywall.st
Azenta CEO Resigns as Interim Leader Reassures Outlook - The Globe and Mail
Why Azenta (AZTA) Stock Is Down Today - Barchart.com
Azenta CEO John Marotta Steps Down; Dr. Martin Madaus Named Interim CEO - Kalkine Media
Azenta appoints interim CEO as John Marotta resigns By Investing.com - Investing.com Nigeria
Azenta Names Martin Madaus Interim CEO, Reaffirms Revenue Guidance - citybiz
AZENTA ANNOUNCES LEADERSHIP TRANSITION - marketscreener.com
Azenta appoints interim CEO as John Marotta resigns - Investing.com India
ETFs Investing in Azenta, Inc. Stocks - TradingView
Azenta (AZTA) Results Check: EPS Beats Its Estimate for the Current Session; Price Move: Shares Move Lower 1.79% in the Available RecordNew Analyst Coverage - vinanet.vn
Azenta, Inc. Earnings Call Balances Growth And Strain - theglobeandmail.com
Azenta, Inc.: Financial Data Forecasts Estimates and Expectations | BA3 | US1143401024 - marketscreener.com
Azenta: Needs To Overcome A Few Hurdles If The Rally Is To Continue (NASDAQ:AZTA) - Seeking Alpha
AZTA Q2 2026 Earnings: EPS Surpasses Estimates by 37.8% on Operational StrengthReturn On Equity - vinanet.vn
Azenta Inc. (AZTA) Edges Higher to $33.53 as Life Sciences Tools Sector StabilizesExhaustion Gap - vinanet.vn
Azenta Inc. (AZTA) Edges Higher by 0.42% as Shares Trade Between Key Support and ResistanceSector Leader Stocks - dars.gov.et
The 5 Most Interesting Analyst Questions From Azenta’s Q2 Earnings Call - Yahoo! Finance Canada
Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue OutlookHas The Bull Case Changed? - webull.com
Azenta (AZTA) SVP Pirogova has 1,085 shares withheld for tax obligations - Stock Titan
Azenta, Inc. Announces Appointment of Erik J. Bello as Chief Accounting Officer, Effective August 31, 2026 - marketscreener.com
Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Healthcare Sector with a 4.41% Potential Upside - DirectorsTalk Interviews
Azenta (AZTA) Holds Steady at $33.39 as Shares Trade Mid-Range Between Support and ResistanceChart Pattern Alerts - dars.gov.et
Weekly Recap: Azenta, Inc. Q3 revenue gain and analyst target raises - TradingView
Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Securities Fraud Investigation Into Azenta, Inc. (AZTA) Continues - The National Law Review
Azenta Inc (AZTA) Stock News Today - TradingKey
Azenta, Inc. $AZTA Stake Cut by Quantinno Capital Management LP - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Azenta, Inc. (AZTA) And Encourages Investors to Connect - The National Law Review
Azenta (AZTA) Is Up 6.7% After Raising 2026 Guidance And Completing $50M Buyback – What’s Changed - Yahoo Finance
Multi-Manager Small Cap Equity Strategies Fund's Azenta Inc(AZTA) Holding History - GuruFocus
Azenta, Inc. 3Q 2026: Revenue $161.18M, EPS $0.05— 10-Q Summary - TradingView
Azenta (Nasdaq: AZTA) sells B Medical unit, books $149M impairment - Stock Titan
Life Science Funding Weakness Hit Azenta’s (AZTA) Outlook - Yahoo Finance
0.00%
0.51%
자본화:
|
볼륨(24시간):